Skip to main content

Proteomic Analysis of Formalin-fixed Prostate Cancer Tissue

Hood BL, Darfler MM, Guiel TG, Furusato B, Lucas DA, Ringeisen BR, Sesterhenn IA, Conrads TP, Veenstra TD, Krizman DB

Publication: Mol Cell Proteomics (2005) • Vol 4 • Page 1741PMID: 16091476View on PubMed

Purpose

The purpose of this paper was to assess the feasibility of conventional proteomic analysis in cells microdissected from formalin-fixed, paraffin-embedded (FFPE) prostate tissue specimens using a biochemical methodology for the recovery of soluble proteins and peptides.

Conclusion

Protein solubilization was achieved in microdissected FFPE cancerous prostate tissue. Subsequent proteomic analysis resulted in the identification of hundreds of unique proteins, including several prostate cancer markers such as prostate-specific antigen (PSA), prostatic acid phosphatase and macrophage inhibitory cytokine-1. Quantitative proteomic profiling of microdissected cells yielded region-specific protein expression as measured by 18O isotope labeling.

Studies (2)

Purpose

To assess the applicability of microdissected cells from FFPE tissue sections for detection and quantitative analysis using microarray analysis following the biochemical recovery of soluble proteins and peptides.

Summary of Findings

PSA was appropriately and dose-dependently detected in serially diluted protein extracts isolated from microdissected prostate regions, indicating successful application of FFPE microdissected cells and the protein microarray platform.
  • Biospecimens

    TissueProstate
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticBenign
    NeoplasticCarcinoma
  • Platforms

    ProteinReverse phase protein microarray
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsAliquot size/volume
    0.05 Dilution factor
    0.125 Dilution factor
    0.25 Dilution factor
    0.50 Dilution factor